Mesothelioma, Malignant Clinical Trials

31 clinical trials for Mesothelioma, Malignant across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• SW-682 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma — RECRUITING · PHASE2
• A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas — RECRUITING · PHASE1
• SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma — RECRUITING · PHASE1
• A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing — RECRUITING
• Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma — RECRUITING · NA
• HTL0039732 in Participants With Advanced Solid Tumours — RECRUITING · PHASE1
• First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma — RECRUITING · PHASE2
• First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis. — RECRUITING · NA
• A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer — TERMINATED · PHASE1
• A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants — COMPLETED · PHASE2
• ......SMARTEST Trial...... — COMPLETED · PHASE2
• Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease — SUSPENDED
• NM32-2668 in Adult Patients With Selected Advanced Solid Tumors — TERMINATED · PHASE1
• A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma — WITHDRAWN
• Niraparib Efficacy in Patient With Unresectable Mesothelioma — COMPLETED · PHASE2
• A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM) — COMPLETED
• Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies — ACTIVE_NOT_RECRUITING · PHASE1
• Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma — TERMINATED · PHASE2
• Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration — OTHER · PHASE1
• Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma — TERMINATED · PHASE1
• Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma — OTHER
• Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours — NOT_YET_RECRUITING · PHASE1
• Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma — OTHER · PHASE2
• Immunological Variables Associated to ICI Toxicity in Cancer Patients — OTHER · PHASE2
• Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma — COMPLETED · PHASE2
• 11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM) — COMPLETED
• Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM) — TERMINATED · PHASE2
• Malignant Mesothelioma - Can we Improve Quality of Life — COMPLETED · NA

Refine this search